Conditions: Esophageal Cancer
Intervention Type: Biological
Intervention Name: TTK, LY6K, and IMP-3 peptides
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Biological" intervention "TTK, LY6K, and IMP-3 peptides" on "Esophageal Cancer".
-
Phase I Study of Peptide Vaccination Therapy Using Novel Cancer Testis Antigens for Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma
NCTID: NCT00682227
